HALEON logo

Haleon Pakistan Limited Stock Price

KASE:HALEON Community·PK₨95.8b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 25 Fair Values set on narratives written by author

HALEON Share Price Performance

PK₨818.03
-31.86 (-3.75%)
PK₨818.03
-31.86 (-3.75%)
Price PK₨818.03

HALEON Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with high growth potential.

2 Risks
3 Rewards

Haleon Pakistan Limited Key Details

PK₨41.9b

Revenue

PK₨25.9b

Cost of Revenue

PK₨16.0b

Gross Profit

PK₨10.1b

Other Expenses

PK₨6.0b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
50.93
38.27%
14.23%
0.3%
View Full Analysis

About HALEON

Founded
2015
Employees
450
CEO
Qawi Naseer
WebsiteView website
www.haleon.pk

Haleon Pakistan Limited engages in the manufacture, marketing, and sale of consumer healthcare products in Pakistan, rest of Asia, Africa, Australia, North America, the Middle East, and Europe. The company offers oral health, pain relief, wellness and nutrition, and respiratory health products, as well as over-the-counter pharmaceutical products. It sells its products primarily under the Panadol, CaC-1000 Plus, Sensodyne, paradontax, T-Day, ENO, Hydrozole, Qalsium-D, and Voltral Emulgel brands. The company also exports its products to Vietnam, the Philippines, and East West Africa region. The company was formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited and changed its name to Haleon Pakistan Limited in January 2023. Haleon Pakistan Limited was incorporated in 2015 and is headquartered in Karachi, Pakistan. Haleon Pakistan Limited is a subsidiary of Glaxosmithkline Consumer Healthcare B.V.

Recent HALEON News & Updates

Recent updates

No updates

Haleon Pakistan Limited Competitors